GPR161
Basic information
Region (hg38): 1:168079541-168137667
Links
Phenotypes
GenCC
Source:
- pituitary stalk interruption syndrome (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Medulloblastoma predisposition syndrome | Ad | Oncologic | The condition can involve increased risk of medulloblastoma (and possibly other cancer types), and awareness may allow early disease detection and management | Oncologic | 31609649 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPR161 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 16 | ||||
missense | 38 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 3 | |||||
Total | 0 | 0 | 39 | 7 | 13 |
Variants in GPR161
This is a list of pathogenic ClinVar variants found in the GPR161 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-168085562-T-C | Predisposition to medulloblastoma | Uncertain significance (Aug 04, 2022) | ||
1-168085574-T-G | not specified | Uncertain significance (Jan 24, 2024) | ||
1-168085603-T-A | Uncertain significance (Jan 04, 2024) | |||
1-168085618-GC-G | Medulloblastoma | Uncertain significance (May 02, 2022) | ||
1-168085630-G-A | Likely benign (Apr 16, 2018) | |||
1-168085631-C-T | GPR161-related disorder | Likely benign (Sep 27, 2023) | ||
1-168085647-G-A | not specified | Uncertain significance (May 24, 2024) | ||
1-168085652-G-A | not specified | Uncertain significance (May 09, 2023) | ||
1-168085655-A-C | not specified | Uncertain significance (Jan 30, 2024) | ||
1-168085676-T-G | Medulloblastoma | Uncertain significance (Jun 29, 2022) | ||
1-168085701-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
1-168085708-C-T | Benign (Dec 12, 2023) | |||
1-168085711-A-G | Likely benign (Apr 07, 2018) | |||
1-168085712-A-G | not specified | Uncertain significance (Oct 26, 2021) | ||
1-168085725-A-G | Benign (Apr 16, 2018) | |||
1-168085781-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
1-168087644-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
1-168087674-G-A | Medulloblastoma | Uncertain significance (Aug 30, 2023) | ||
1-168087678-A-G | Medulloblastoma • not specified | Uncertain significance (Jul 17, 2023) | ||
1-168087697-A-T | not specified | Uncertain significance (Aug 04, 2022) | ||
1-168090572-T-C | Medulloblastoma | Uncertain significance (May 23, 2022) | ||
1-168090624-G-C | not specified | Uncertain significance (Jan 17, 2024) | ||
1-168090628-A-G | Benign (Feb 01, 2024) | |||
1-168090662-C-T | Uncertain significance (Dec 31, 2023) | |||
1-168096494-A-T | Likely benign (Jan 10, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPR161 | protein_coding | protein_coding | ENST00000537209 | 6 | 52825 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000349 | 0.990 | 125693 | 0 | 55 | 125748 | 0.000219 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.51 | 254 | 332 | 0.766 | 0.0000196 | 3568 |
Missense in Polyphen | 71 | 109.12 | 0.65066 | 1177 | ||
Synonymous | -1.54 | 161 | 138 | 1.17 | 0.00000858 | 1146 |
Loss of Function | 2.28 | 9 | 20.0 | 0.450 | 0.00000104 | 212 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000376 | 0.000376 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000292 | 0.000290 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000264 | 0.000261 |
Other | 0.000332 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Key negative regulator of Shh signaling, which promotes the processing of GLI3 into GLI3R during neural tube development. Recruited by TULP3 and the IFT-A complex to primary cilia and acts as a regulator of the PKA-dependent basal repression machinery in Shh signaling by increasing cAMP levels, leading to promote the PKA-dependent processing of GLI3 into GLI3R and repress the Shh signaling. In presence of SHH, it is removed from primary cilia and is internalized into recycling endosomes, preventing its activity and allowing activation of the Shh signaling. Its ligand is unknown (By similarity). {ECO:0000250}.;
- Pathway
- Hedgehog signaling pathway - Homo sapiens (human);Hedgehog Signaling Pathway;GPCRs, Class A Rhodopsin-like;Signal Transduction;Hedgehog ,off, state;Signaling by Hedgehog
(Consensus)
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.584
- rvis_EVS
- -0.8
- rvis_percentile_EVS
- 12.33
Haploinsufficiency Scores
- pHI
- 0.156
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.555
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0652
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpr161
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; craniofacial phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; pigmentation phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; vision/eye phenotype;
Zebrafish Information Network
- Gene name
- gpr161
- Affected structure
- anterior lateral plate mesoderm
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- adenylate cyclase-activating G protein-coupled receptor signaling pathway;multicellular organism development;negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning
- Cellular component
- cilium;integral component of membrane;endocytic vesicle membrane;recycling endosome;ciliary membrane
- Molecular function
- G protein-coupled receptor activity